NPS RADAR April 2010NPS RADAR April 2010

NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.

Find out more about NPS RADAR.



Title Why read this
NPS RADAR April 2010 Professional publication - NPS RADAR - Complete issue NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Dabigatran (Pradaxa) for preventing venous thromboembolism after hip or knee replacement surgery Professional publication - NPS RADAR - Review Dabigatran is an oral direct thrombin inhibitor anticoagulant. It is approved for short-term use to prevent deep vein thrombosis and pulmonary embolism after total hip or total knee replacement surgery.
Postmarketing reports of acute pancreatitis with sitagliptin products (Janumet, Januvia) Professional publication - NPS RADAR - Brief item Cases of acute pancreatitis have been reported with sitagliptin and sitagliptin with metformin. Be alert for signs and symptoms in patients taking these products, and use cautiously in people with a history of pancreatitis.
Extended PBS listings for zoledronic acid 5mg (Aclasta) Professional publication - NPS RADAR - Brief item From 1 April 2010 zoledronic acid can be prescribed for men with osteoporosis with or without fracture, for people with corticosteroid-induced osteoporosis or for people with symptomatic Paget’s disease.
Rizatriptan (Maxalt) 10 mg wafers for migraine, and revised listings for other 5HT1 agonists (‘triptans’) Professional publication - NPS RADAR - Brief item Rizatriptan (Maxalt) 10 mg wafer for migraine, and revised listings for other 5HT1 agonists (‘triptans’)

Complete list of all NPS RADAR content.

Find out more about NPS RADAR.

Date published: 2010-04-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.